SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

On Monday the share price of Medical Marijuana Inc (OTCMKTS:MJNA) declined more than 6% to close the trading session at $0.0610. It marks a new 52-week low for MJNA ticker and its seventh successive red close. The decline came at a share volume of 8.39 million compared to average share volume of 3.60 million. Even on Friday, the stock price declined 5.5% to close at $0.065.

The buzz

Medical Marijuana issued a press release after the closing bell on Friday. It disclosed that its recently acquired firm Kannaway was recognized with the esteemed “Startup of the year” accolade. The award was presented by the Academy of Multi-Level Marketing, probably an institution which may or may not exist at all. The market ignored the news and posted another drastic red session. It was very much expected as the press release didn’t contain anything significant, particularly in the absence of annual report.

The extension

Medical Marijuana filed an application to get a later date to file its 2014 annual report. However, the extended data has even gone, in fact almost by one month. It is prime reason the company stock shows up as ‘Dark of Defunct’ and is termed as “Pink No Information.” It even has the STOP sign on page. The momentum on Monday made it clear that investors are looking for substantial information related to financial numbers, and no other press release seems to be convincing at this time.

The sector problem

As of now, Medical Marijuana is not the only marijuana company having trouble with stock price performance. Mostly, all the big OTC marijuana companies of last year are trading around 52-week lows and finding it really hard to maintain their strong daily volume and interest that was witnessed in 2014. The confidence in marijuana stocks is declining rapidly, and showing no signs of quick revival.

SHARE
Previous articleWhy Anavex Life Sciences Corp (OTCMKTS:AVXL) Is Encouraged From Latest Findings?
Next articleNanoTech Entertainment, Inc. (OTCMKTS:NTEK) Completes Acquisition Of UpLink.to
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.